Product Description
Overall, the global men’s reproductive health device market was valued at over $289 million in 2024. This is expected to increase over the forecast period at a CAGR of 2.5% to reach over $343 million.
The full report suite on the global market for men’s reproductive health devices includes inflatable and malleable erectile dysfunction (ED) devices.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL MEN’S REPRODUCTIVE HEALTH MARKET TRENDS
The incidence of erectile dysfunction is strongly correlated with BPH and prostate cancer treatment. The rates of ED in radical prostatectomy (RP) and radiation groups are similar, although the onset of ED is often later in patients treated with radiation therapy.
GLOBAL MEN’S REPRODUCTIVE HEALTH MARKET SHARE INSIGHTS
- Boston Scientific led the global erectile dysfunction device market in 2024. The company offers a broad line of penile implant devices, including the AMS 700™ MS series of three-piece inflatable devices, AMS Ambicor® two-piece inflatable device and others. The company’s strong position in the market resulted from its 2018 acquisition of American Medical Systems (AMS)
- Coloplast was the second-leading competitor in the men’s reproductive health device market in 2024. Coloplast offers its Titan® line of inflatable penile prosthesis products as well as malleable penile prostheses.
- Rigicon, the newest entrant to the industry, gained a modest share in the total erectile dysfunction device market. The company offers Rigi10™ and Infla10® product lines of malleable and inflatable penile prosthesis, respectively.
GLOBAL MEN’S REPRODUCTIVE HEALTH MARKET SEGMENTATION SUMMARY
- Men’s Reproductive Health Devices – Further Segmented Into:
- Device Type: Inflatable Erectile Dysfunction Device, and Malleable Erectile Dysfunction Devices
GLOBAL RESEARCH SCOPE
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2024 |
| Forecast | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
This MedCore is also found in the full report suite titled Urology Market which contains several other extremities medical device markets.
